|
ANKHD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.57380000000474E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.21170000000282E-05 |
| Normal-vs-Stage2 |
2.183200E-01 |
| Normal-vs-Stage3 |
1.294830E-01 |
| Normal-vs-Stage4 |
3.189000E-01 |
| Stage1-vs-Stage2 |
3.777400E-01 |
| Stage1-vs-Stage3 |
4.070000E-01 |
| Stage1-vs-Stage4 |
6.268800E-01 |
| Stage2-vs-Stage3 |
9.132200E-01 |
| Stage2-vs-Stage4 |
8.962200E-01 |
| Stage3-vs-Stage4 |
9.618600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.03659999999229E-05 |
| Normal-vs-AfricanAmerican |
5.076300E-03 |
| Normal-vs-Asian |
4.845600E-01 |
| Caucasian-vs-AfricanAmerican |
6.109800E-01 |
| Caucasian-vs-Asian |
6.740000E-01 |
| AfricanAmerican-vs-Asian |
7.936400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.86126999999203E-05 |
| Normal-vs-Female |
4.414100E-02 |
| Male-vs-Female |
7.973900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.643600E-03 |
| Normal-vs-Extreme_Weight |
2.91669999996635E-06 |
| Normal-vs-Obese |
1.711780E-02 |
| Normal-vs-Extreme_Obese |
1.824420E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.202000E-01 |
| Normal_Weight-vs-Obese |
5.395000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.222000E-01 |
| Extreme_Weight-vs-Obese |
5.911900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.943800E-01 |
| Obese-vs-Extreme_Obese |
2.781200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.063000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.067500E-02 |
| Normal-vs-Age(61-80Yrs) |
3.17289999995918E-06 |
| Normal-vs-Age(81-100Yrs) |
1.287510E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.263200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.529000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.307400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.897780E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.923580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.455600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.57650000001775E-06 |
| Normal-VS-Type2 PRCC |
6.240500E-02 |
| Normal-VS-KIRP CIMP |
2.637500E-04 |
| Normal-VS-Unclassified PRCC |
1.245780E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.251700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.522800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.393200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.602390E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.234400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.914350E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.964200E-03 |
| Normal-vs-N1 |
6.449200E-01 |
| Normal-vs-N2 |
3.782100E-03 |
| N0-vs-N1 |
1.771980E-01 |
| N0-vs-N2 |
4.479400E-01 |
| N1-vs-N2 |
2.692800E-01 |
|
|
